With New Contrast Agent, MRI Detects Micrometastases in Mice (IMAGE)
Caption
For earlier detection of metastases, Case Western Reserve University researchers developed a magnetic resonance imaging contrast agent that includes a probe that binds to fibrin-fibronectin complexes found in aggressive breast cancers. Fibronectin is expressed by high-risk primary and metastatic tumors, distinguishing them from normal tissue.
Credit
Zheng-Rong Lu
Usage Restrictions
Please give proper credit.
License
Licensed content